531681 — Amerise Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹56.16m
- IN₹55.94m
- IN₹1.88m
Annual cashflow statement for Amerise Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.37 | 5.49 | -1.19 | -1.46 | -0.076 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0 | — | 0 | 0 |
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.574 | -4.88 | -0.132 | -0.232 | -30.6 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.94 | 0.614 | -1.32 | -1.69 | -30.7 |
| Capital Expenditures | — | — | — | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.89 | -1.5 | 1.25 | 2.67 | 30.7 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.89 | -1.5 | 1.25 | 2.67 | 30.7 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.827 | 0.073 | -0.9 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.058 | -0.064 | 0.007 | 0.075 | -0.011 |